Issels Integrative Immuno-Oncology September 7, 2017  

FDA Gives Quick Approval for New Cancer Treatment


Dear Friend,

Researchers have made a number of significant breakthroughs in cancer treatment, but a recent development has the healthcare community particularly excited. The Food and Drug Administration (FDA) has approved a drug that treats tumors based on a genetic abnormality.

Keytruda: A Landmark in Immunotherapy for Cancer

Pembrolizumab, marketed under the trade name Keytruda, was tested on a trial group of 86 patients. The results were remarkable: 66 patients saw their tumors shrink and stabilize, while the tumors in 18 of them disappeared with no recurrence.

What's different about Keytruda? It's the first drug that attacks tumors from a shared genetic profile rather than the actual location of the tumor. A prospective patient first undergoes testing to determine whether he or she is a genetic match for the mutations targeted by Keytruda.

Current and Future Possibilities

At present, Keytruda is approved for treating only select forms of advanced bladder, lung and melanoma tumors. The drug will be effective for approximately four percent of cancer patients, which still equates to tens of thousands of people.

Scientists are encouraged by the possibility of further treatment methods tailored to a patient's specific genetic profile. This ability would greatly enhance development of more accurate targeting and treatment.

Advanced Immunotherapy for Cancer Treatment from Issels®

Issels® uses genomic testing to determine a patient's individual treatment needs. We then use the information to tailor a personalized immunotherapy for cancer program including methods such as vaccines and NK cells.

We have helped patients with all forms of cancer achieve long-term remission. Contact us to learn more about the Issels® Difference and what it can do for you

FDA Gives Quick Approval for New Cancer Treatment

Read more interesting articles on the "Issels Cancer Immunotherapy" news/blog posted every Tuesday and Thursday. Check It Out Now »


Coaches versus Cancer – $100 Million Raised for Research

Actors, athletes and other high-profile people often use their celebrity to help promote awareness of cancer research. One such program is Coaches vs. Cancer, which has raised more than $100 million to support the American Cancer Society (ACS).

Get the Full Story!

Abdomen Fat Raises Cancer Risk

The study, conducted by scientists at the International Agency for Research on Cancer (IARC) of the World Health Organization, was the first to compare adult body measurements in a standardized way. Data was obtained from 43,000 participants, 1,600 of who had been diagnosed with an obesity-related cancer, and who were observed over an average of 12 years.

Results showed that an additional four inches added to the waistline equated to a 13 percent increase in the risk for obesity-related cancers. More significantly, adding three inches to the hips can boost the risk of bowel cancer by 15 percent.

Get the Full Story!

Videos – What Do Patients Say About Their Experience?

Watch videos of patients who share their own experiences at the Issels clinics with you. Listen to their stories and cancer journeys.

Get the Full Story!
Interested?

Learn More

Testimonials »

Treatments »

Vaccines »

Statistics »

History »

Locations »

Contact Us »

Connect With Us:


Google +

Contact Info:

Phone: 888-447-7357

Email: info@issels.com



Treatments | Testimonials | Contact Us